PMV Pharmaceuticals, Inc.
PMVP
$1.48
$0.010.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.63% | -63.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.10% | -14.32% | |||
| Operating Income | -6.10% | 14.32% | |||
| Income Before Tax | -8.01% | 14.64% | |||
| Income Tax Expenses | 100.23% | -- | |||
| Earnings from Continuing Operations | -21.64% | 24.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.64% | 24.19% | |||
| EBIT | -6.10% | 14.32% | |||
| EBITDA | -6.13% | 14.33% | |||
| EPS Basic | -21.51% | 24.40% | |||
| Normalized Basic EPS | -7.87% | 14.85% | |||
| EPS Diluted | -21.51% | 24.40% | |||
| Normalized Diluted EPS | -7.87% | 14.85% | |||
| Average Basic Shares Outstanding | 0.11% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||